Ventis Pharma Corporation is a biopharmaceutical company focused on developing and producing innovative pain management therapies. We create solutions to treat patients with a variety of post-operative pain and pain syndromes.
We develop safe, effective, and suitable therapies for a wide variety of patient applications that serve both adults and children.
We currently hold multiple patents, or have patents pending, in the US and 40 other countries for our long-acting, low-toxicity local anesthetic formulation, Enduracaine™. At Ventis Pharma, we conduct ongoing research and development activities for adjuvant agents to prolong pain relief interventions in a wide variety of patient care situations.
Quite simply, our company focuses on developing innovative pain management solutions for medical professionals and their patients.
To significantly improve patient care by providing safe, low-toxicity, and cost-effective solutions that eliminate the need for perioperative narcotics.
Ventis Pharma Corporation strives to become a world leader in advancing pain management solutions. Our innovative, long-acting, low-toxicity products are designed to reduce surgical pain and treat chronic pain conditions safely and effectively. By making our products cost-effective and available throughout the world, we can improve the quality of life for all patients.